HOME >> MEDICINE >> NEWS
New drug target might sidestep gleevec resistance, Jefferson scientists show

(PHILADELPHIA) -- Though enormously successful, the leukemia drug Gleevec has some downsides. Recent studies have linked the drug to heart failure in a small number of patients, and drug resistance continues to be a problem. But now, researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia may have found a new way to sidestep such resistance. They have discovered that by reactivating a protein that is normally shut off in leukemia and in Gleevec-resistant cancer cells, leukemia development is halted.

A drug that could turn on the gene that makes the protein C/EBP-alpha, a "transcription factor" required for cells to differentiate, then, might control or even eliminate the cancer.

According to Bruno Calabretta, M.D., Ph.D., professor of cancer biology at Jefferson Medical College of Thomas Jefferson University, transcription factors are molecular switches that turn on genes when their function is needed. C/EBP-alpha expression is low in leukemia cells such as those with the BCR-ABL protein defect, which causes chronic myeloid leukemia (CML), a disease that Gleevec treats so well.

Gleevec is normally prescribed for patients early on in CML, which is characterized by an overabundance of white blood cells. But when the disease advances to the terminal stage, or "blast crisis" phase, the cells, called blasts, remain undifferentiated and accumulate rather than becoming more mature white blood cells called granulocytes. Gleevec is much less effective in this stage, Dr. Calabretta says. Yet, in leukemia cells that respond to treatment with Gleevec, expression of C/EBP-alpha increases.

The researchers looked at what might happen if C/EBP-alpha was turned back on in blast crisis patients and in CML patients who were resistant to Gleevec. Reporting in the journal Blood, they found that in both the laboratory and in mice, immature white blood cells began to differen
'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
15-Sep-2006


Page: 1 2 3

Related medicine news :

1. NIH scientists target future pandemic strains of H5N1 avian influenza
2. Nottingham center to help UK to meet its carbon targets
3. Wesley Research Institute study targets pharmacists to help diabetes sufferers
4. Dead on target
5. Drug eluting nanostructured coatings enable targeted drug therapy for orthopedic patients
6. New therapeutic targets for neurodegenerative diseases
7. Animal study identifies promising new target for brain tumor therapy
8. Combined molecular-targeted and hormonal therapies offer promise in treating ovarian cancer
9. New mechanism identified for resistance to targeted lung cancer drugs
10. Head and neck cancer vaccine targets proteins to create immune response
11. New class of HIV drug attacks previously untargeted enzyme

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 31, 2020 , ... Today Hinge Health, ... expansion of clinical & technical capabilities to cover the full continuum of care ... joint health solution. , Currently, employers interested in truly solving their MSK ...
(Date:7/22/2020)... ... , ... Ocean Tomo Transactions, LLC will auction a patent ... Brock University for jurisdictions throughout North America, Europe and Asia. Ocean Tomo ... manufacturing processes of novel opioid related compositions for pain management as well as ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... “Frozen.” It’s ... to a shoulder joint – oftentimes for unknown reasons – resulting in stiffness, persistent ... MD , an expert in treating problems of the upper limbs and joints and ...
(Date:7/18/2020)... ... July 18, 2020 , ... When the federal government extended ... opportunity for small and some bigger businesses to obtain a PPP loan. But the ... the “GIG Economy” do not realize they are eligible. , While 4.9 million ...
(Date:7/10/2020)... ... July 09, 2020 , ... CellTrak, ... behavioral health announces that Ohio Department of Medicaid has awarded CellTrak Phase 2 ... agencies in Ohio already rely on CellTrak for EVV – both as a ...
Breaking Medicine News(10 mins):
(Date:7/10/2020)... ... July 10, 2020 , ... The Dolphin Company, the ... more than 12 million guests, unveiled its new comprehensive plan of protocols and ... in all facets of the operation, safety, and health addressing COVID-19. , Experts ...
(Date:7/10/2020)... FRANCISCO, Calif. (PRWEB) , ... ... ... Pharmaceutical Review , the leading review of business and technology for the ... cover the development and manufacturing of the highest quality pharmaceutical products. ...
(Date:7/7/2020)... ... July 07, 2020 , ... To support those on the ... Change (WGC), will be providing meals to the employees of Southern Nevada Health District. ... throughout Las Vegas on Wednesday, July 8th. , When asked why the Women of ...
Breaking Medicine Technology:
Cached News: